Collegium Pharma Cash Flow - Annual (NASDAQ:COLL)

Add to My Stocks
$15.3 $0.38 (2.42%) COLL stock closing price Sep 21, 2018 (Closing)

The Collegium Pharma cash flow statement is one of the important reports considered by investors doing a fundamental analysis of the company. While its important to look at the Collegium Pharma debt position, the cash flow statement becomes equally important because public companies use accrual accounting. For example, if a company sells a product which gets counted as Collegium Pharma revenue but does not convert to cash because it does not receive payment in the same quarter, it affects the cash position for that period. The cash flow statement is essetial while conducting the Collegium Pharma cash flow analysis and can be used to measure the operating performance of Collegium Pharma compared to various industry peers like CYNA stock and RIGL stock. Collegium Pharma has a negative cash and cash equivalents change of $-34.52M.

View details of Collegium Pharma cash flows for latest & last 10 financial years
show more
Fiscal year is Jan - Dec20172016201520142013
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow-----
Net Increase (Decrease) in Assets Liabilities-2.5M12.71M3.33M-0.21M-0.63M
Cash From (used in) Discontinued Operations-----
Other Adjustments Net9.75M5.75M2.18M--
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-0.99M-0.47M-0.36M-0.01M-0.2M
Acquisition Disposition of Subsidiaires-----
Increase (Decrease) in Investments-----
Other Cash Inflow (Outflow) from Investment Activities--2.5M---
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares36.21M138.22M117.35M-11.95M
Issuance (Repayment) of Debt Securities-2.66M-2.66M-1.34M11.96M-
Increase (Decrease) in Bank & Other Borrowings-----
Payment of Dividends & Other Cash Distributions-----
Other Cash from (used by) Financing Activities-0.06M--0.01M--
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash-----
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year153.22M95.69M1.63M7.55M11.93M
Cash & Equivalents at Year End118.69M153.22M95.69M1.63M7.55M
All figures in USD. M: Millions of USD, B: Billions of USD.

Collegium Pharma stock price history provides insight into historical stock price fluctuations, and Collegium Pharma stock comparison chart enables peer comparison. Some of the key terms used in the statement of cash flows are:

  • Net Change in Cash and Cash Equivalents: A positive net change in cash and cash equivalents shows that Collegium Pharma is able to meet its expenditure and grow cash at hand which demonstrates the financial strength of the company's balance sheet. Also see - Collegium Pharma stock price movement.
  • Cash Flow from operating activities: Collegium Pharma reported a negative operating cash flow of $-67.01M for 2017 and has seen an increase from the previous year. Operating cash flow comes from main business activities. Investors look for positive cash flow from recurring operating activities.
  • Cash Flow from investment activities: Collegium Pharma used $-0.99M cash due to investment activities. It includes the use of cash outside of normal day to day activities like buying fixed assets, plant and machinery etc.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $33.48M for Collegium Pharma.

Key Financial Ratios For Collegium Pharma Cash Flow

FCF margin